Patent 9585887 was granted and assigned to Tangent Reprofiling Limited on March, 2017 by the United States Patent and Trademark Office.
The present specification discloses compositions comprising at least one therapeutic compound capable of modulating androgen production and methods and uses for treating a disorder associated with androgen production using such compositions and/or compounds.